Literature DB >> 25308836

Inhibition of autophagy by chloroquine potentiates synergistically anti-cancer property of artemisinin by promoting ROS dependent apoptosis.

Arnab Ganguli1, Diptiman Choudhury1, Satabdi Datta1, Surela Bhattacharya1, Gopal Chakrabarti2.   

Abstract

Artemisinin (ART) is a well-known anti-malarial drug, and recently it is shown prospective to selectively kill cancer cells. But low potency makes it inappropriate for use as an anticancer drug. In this study, we modulated the ART-induced autophagy to increase Potency of ART as an anticancer agent. ART reduced the cell viability and colony forming ability of non-small lung carcinoma (A549) cells and it was non-toxic against normal lung (WI38) cells. ART induced autophagy at the early stage of treatment. Pre-treatment with chloroquine (CQ) and followed by ART treatment had synergistic combination index (CI) for cell death. Inhibition of autophagy by CQ pre-treatment led to accumulation of acidic vacuoles (AVOs) which acquainted with unprocessed damage mitochondria that subsequently promoted ROS generation, and resulted releases of Cyt C in cytosol that caused caspase-3 dependent apoptosis cell death in ART-treated A549 cells. Scavenging of ROS by antioxidant N-acetyl-cysteine (NAC) inhibited caspase-3 activity and rescued the cells from apoptosis. Similar effects were observed in other cancer cells SCC25 and MDA-MB-231. The appropriate manipulation of autophagy by using CQ provides a powerful strategy to increase the Potency of selective anticancer property of ART.
Copyright © 2014 Elsevier B.V. and Société française de biochimie et biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Anticancer agent; Apoptosis; Artemisinin; Autophagy; Chloroquine

Mesh:

Substances:

Year:  2014        PMID: 25308836     DOI: 10.1016/j.biochi.2014.10.001

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  30 in total

1.  Dihydroartemisinin beneficially regulates splenic immune cell heterogeneity through the SOD3-JNK-AP-1 axis.

Authors:  Yiwei Zhang; Qilong Li; Ning Jiang; Ziwei Su; Quan Yuan; Lei Lv; Xiaoyu Sang; Ran Chen; Ying Feng; Qijun Chen
Journal:  Sci China Life Sci       Date:  2022-02-23       Impact factor: 10.372

Review 2.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

3.  Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models.

Authors:  Janice M Santiago-O'Farrill; S John Weroha; Xiaonan Hou; Ann L Oberg; Ethan P Heinzen; Matthew J Maurer; Lan Pang; Philip Rask; Ravi K Amaravadi; Sarah E Becker; Ignacio Romero; Ma Jesús Rubio; Xavier Matias-Guiu; Maria Santacana; Antonio Llombart-Cussac; Andrés Poveda; Zhen Lu; Robert C Bast
Journal:  Cancer       Date:  2019-11-12       Impact factor: 6.860

4.  Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis.

Authors:  Richa Mishra; Sakshi Kohli; Nitish Malhotra; Parijat Bandyopadhyay; Mansi Mehta; MohamedHusen Munshi; Vasista Adiga; Vijay Kamal Ahuja; Radha K Shandil; Raju S Rajmani; Aswin Sai Narain Seshasayee; Amit Singh
Journal:  Sci Transl Med       Date:  2019-11-13       Impact factor: 17.956

5.  Synergistic effect of Chloroquine and Panobinostat in ovarian cancer through induction of DNA damage and inhibition of DNA repair.

Authors:  María Ovejero-Sánchez; Rogelio González-Sarmiento; Ana Belén Herrero
Journal:  Neoplasia       Date:  2021-04-27       Impact factor: 5.715

6.  Epigallocatechin-3-gallate enhances the therapeutic effects of leptomycin B on human lung cancer a549 cells.

Authors:  Meghan M Cromie; Weimin Gao
Journal:  Oxid Med Cell Longev       Date:  2015-04-01       Impact factor: 6.543

7.  pH-Responsive Artesunate Polymer Prodrugs with Enhanced Ablation Effect on Rodent Xenograft Colon Cancer.

Authors:  Dan-Li Hao; Ran Xie; Ge-Jing De; Hong Yi; Chen Zang; Mi-Yi Yang; Li Liu; Hai Ma; Wei-Yan Cai; Qing-He Zhao; Feng Sui; Yan-Jun Chen
Journal:  Int J Nanomedicine       Date:  2020-03-16

Review 8.  Progress in Redirecting Antiparasitic Drugs for Cancer Treatment.

Authors:  Haoyang Huang; Qing He; Binghua Guo; Xudong Xu; Yinjuan Wu; Xuerong Li
Journal:  Drug Des Devel Ther       Date:  2021-06-22       Impact factor: 4.162

Review 9.  Novel Approaches of Dysregulating Lysosome Functions in Cancer Cells by Specific Drugs and Its Nanoformulations: A Smart Approach of Modern Therapeutics.

Authors:  Khaled S Allemailem; Ahmad Almatroudi; Faris Alrumaihi; Saleh A Almatroodi; Mohammad O Alkurbi; Ghaiyda Talal Basfar; Arshad Husain Rahmani; Amjad Ali Khan
Journal:  Int J Nanomedicine       Date:  2021-07-26

10.  Lithium protects dopaminergic cells from rotenone toxicity via autophagy enhancement.

Authors:  Lingling Hou; Nian Xiong; Ling Liu; Jinsha Huang; Chao Han; Guoxin Zhang; Jie Li; Xiaoyun Xu; Zhicheng Lin; Tao Wang
Journal:  BMC Neurosci       Date:  2015-11-25       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.